Concepedia

Pengfei Su

PS

Statistics

Publications

8

Citations

315

H-Index

8

Active since

2017

Affiliations

Peking Union Medical College Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

The First People's Hospital of Shunde

Southern Medical University

Pengfei Su is an author at Peking Union Medical College Hospital specializing in medicine, tumor biology, and cancer biology.

ORCID

Top concepts

Publications per year

2017–2024

8

Publications

8

Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells

Pengfei Su, Yong Yang, Guoxin Wang et al. · International Journal of Oncology · 2018 · 92 citations · Full text

, , +19

Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5/PI3K/AKT/mTOR pathway in gastric cancer

Pengfei Su, Lin Jiang, Yingjing Zhang et al. · Cancer Cell International · 2022 · 75 citations · Full text

Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer

Yong Yang, Guoxin Wang, Dajian Zhu et al. · International Journal of Oncology · 2017 · 47 citations · Full text

, , +14

Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p/EIF5A2 pathway

Lin Jiang, Yingjing Zhang, Pengfei Su et al. · Translational Oncology · 2022 · 30 citations · Full text

Urolithin A suppresses tumor progression and induces autophagy in gastric cancer via the PI3K/Akt/mTOR pathway

Yingjing Zhang, Lin Jiang, Pengfei Su et al. · Drug Development Research · 2022 · 26 citations

, , +19

1–5 of 8